Press Release Nov 18 2020
Filed with NSE · · 3 pages · English
Summary by 6ix AI
The company signed a licensing agreement with MultiG for the distribution of this test kit across various markets. The kit is designed to provide results within a short time frame and has already been commercialized in multiple countries. Cipla aims to enhance global access to essential diagnostic tools through this initiative.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Cipla
- Press Release Nov 06 2020
- Press Release Oct 28 2020
- Press Release Oct 20 2020
- Press Release Oct 12 2020
- Press Release Sep 25 2020
Later from Cipla
- Press Release Dec 11 2020
- Press Release Dec 16 2020
- Press Release Dec 18 2020
- Press Release Jan 27 2021
- Press Release Jan 29 2021
Follow Cipla into a list and get an email when it puts out news.
Follow Cipla